COVID-19

(YakobchukOlena/iStock via Getty Images Plus)

CRAACO 2020

CRAACO event unites clinical research and care

By Jenni Spinner

This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.

(peterschreiber.media/iStock via Getty Images Plus)

FDA okays first COVID-19 treatment

By Jenni Spinner

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

(olegback/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

(ismagilov/iStock via Getty Images Plus)

Current FDA COVID-19 advice and actions

By Jenni Spinner

The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.

(Mironov Konstantin/iStock via Getty Images Plus)

hyperCORE names new CEO

By Jenni Spinner

The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.

(fizkes/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI, Pharmapack Europe to return in 2021

By Jenni Spinner

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

(Egor Shabanov/iStock via Getty Images Plus)

FDA COVID-19 response roundup

By Jenni Spinner

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

(Vacclav/iStock via Getty Images Plus)

Trump and COVID-19: treatments to date

By Jenni Spinner

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

(Nadzeya_Dzivakova/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Index survey reveals minds of CEOs

By Jenni Spinner

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.

(monsitj/iStock via Getty Images Plus)

Phesi: COVID-19 fueling trial suspensions

By Jenni Spinner

A recent study from the clinical research services firm indicates the pandemic continues to significantly impact clinical trial sites around the globe.

(Anastasia Usenko/iStock via Getty Images Plus)

Deloitte survey reveals pharma CEO thoughts

By Jenni Spinner

The latest iteration of the company’s Pharma CEO Survey offers information and insight as to how key industry figures are planning for the future.

(ChakisAtelier/iStock via Getty Images Plus)

Latest COVID-19 news from the FDA

By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

(solarseven/iStock via Getty Images Plus)

Platform forecasts COVID-19 trial outcomes

By Jenni Spinner

The technology from Opyl uses artificial intelligence to anticipate a COVID-19 treatment, vaccine, diagnostic or device’s chances of success in a study.

Follow us

Products

View more

Webinars